Achromatopsia: On the Doorstep of a Possible Therapy

Publisher： Karger

E-ISSN： 1423-0259|54|2|103-108

ISSN： 0030-3747

Source： Ophthalmic Research, Vol.54, Iss.2, 2015-08, pp. : 103-108

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Clinical features of achromatopsia in Swedish patients with defined genotypes

By Eksandh Louise   Kohl Susanne   Wissinger Bernd  

Ophthalmic Genetics, Vol. 23, Iss. 2, 2002-06 ,pp. : 109-120

Informa Healthcare

Access to resources Recommend Favorite

Cystoid Macular Edema: Possible Complication of Infliximab Therapy in Behçet’s Disease

By  

Case Reports in Ophthalmology, Vol. 1, Iss. 1, 2010-06 ,pp. : 14-19

Karger

Access to resources Recommend Favorite

Molecular Genetics of Achromatopsia in Newfoundland Reveal Genetic Heterogeneity, Founder Effects and the First Cases of Jalili Syndrome in North America

By Doucette Lance  

Ophthalmic Genetics, Vol. 34, Iss. 3, 2013-09 ,pp. : 119-129

Informa Healthcare

Access to resources Recommend Favorite

TNP-470 (a fungus-derived inhibitor of angiogenesis) reduces proliferation of cultured fibroblasts isolated from primary pterygia: a possible drug therapy for pterygia

By Kria Lidia   Ohira Akihiro   Amemiya Tsugio  

Current Eye Research, Vol. 17, Iss. 10, 1998-10 ,pp. : 986-993

Informa Healthcare

Access to resources Recommend Favorite

Possible Involvement of Nitric Oxide in the Progression of Diabetic Retinopathy

By  

Ophthalmologica, Vol. 217, Iss. 5, 2003-08 ,pp. : 342-346

Karger

Access to resources Recommend Favorite